Efficacy and safety of 6 or 8 weeks of simeprevir,...

Journal of Viral Hepatitis 2017 / 12

Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection

Sulkowski, M. S., Feld, J. J., Lawitz, E., Felizarta, F., Corregidor, A. M., Khalid, O., Ghalib, R., Smith, W. B., Van Eygen, V., Luo, D., Vijgen, L., Gamil, M., Kakuda, T. N., Ouwerkerk-Mahadevan, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Viral Hepatitis
DOI:
10.1111/jvh.12853
Date:
December, 2017
File:
PDF, 249 KB
english, 2017
Conversion to is in progress
Conversion to is failed